General Cannabis(DE:7A7)
€0.100.00 (0.00%)
DE:7A7
General Cannabis financials statements
€0.10
At close:0.00 (0.00%)
General Cannabis (7A7) Ratios
1 Followers
General Cannabis Ratios
DE:7A7's free cash flow for Q4 2024 was $-177.19K. For the 2024 fiscal year, DE:7A7's free cash flow was decreased by $-4.98K and operating cash flow was $-172.21K. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.08 | 0.16 | 0.32 | 0.81 | 0.85 |
| Quick Ratio | 0.07 | 0.08 | 0.20 | 0.47 | 0.58 |
| Cash Ratio | 0.06 | 0.03 | 0.13 | 0.42 | 0.50 |
| Solvency Ratio | -0.02 | -0.11 | -0.19 | -0.36 | -0.63 |
| Operating Cash Flow Ratio | -0.06 | -0.09 | -0.15 | -0.33 | -0.65 |
| Short-Term Operating Cash Flow Coverage | -0.07 | -0.81 | -1.03 | -1.08 | -2.42 |
| Net Current Asset Value | $ -24.52M | $ -22.63M | $ -20.74M | $ -20.34M | $ -8.94M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 1.01 | 0.83 | 0.77 | 0.71 | 0.46 |
| Debt-to-Equity Ratio | -5.80 | -5.64 | 120.66 | 3.52 | 1.06 |
| Debt-to-Capital Ratio | 1.21 | 1.22 | 0.99 | 0.78 | 0.51 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 1.25 | 0.99 | 0.71 | 0.38 |
| Financial Leverage Ratio | -5.76 | -6.76 | 156.91 | 4.95 | 2.29 |
| Debt Service Coverage Ratio | 0.05 | -0.03 | -0.50 | -0.65 | -2.55 |
| Interest Coverage Ratio | 0.59 | -0.28 | -1.54 | -1.13 | -2.30 |
| Debt to Market Cap | 5.43 | 8.15 | 1.91 | 1.23 | 0.46 |
| Interest Debt Per Share | 0.22 | 0.18 | 0.17 | 0.26 | 0.16 |
| Net Debt to EBITDA | 18.74 | 18.98 | -10.32 | -7.02 | -1.32 |
| Profitability Margins | |||||
| Gross Profit Margin | 46.05% | 39.88% | 36.24% | 36.20% | 25.10% |
| EBIT Margin | 6.11% | -0.15% | -23.81% | -23.61% | -120.05% |
| EBITDA Margin | 9.75% | 6.60% | -9.03% | -21.15% | -103.32% |
| Operating Profit Margin | 6.11% | -5.11% | -21.91% | -23.61% | -50.83% |
| Pretax Profit Margin | -7.22% | -18.22% | -38.01% | -68.99% | -142.18% |
| Net Profit Margin | -7.22% | -25.49% | -39.05% | -70.52% | -149.64% |
| Continuous Operations Profit Margin | -7.22% | -25.49% | -39.05% | -70.52% | -142.18% |
| Net Income Per EBT | 100.05% | 139.92% | 102.72% | 102.21% | 105.25% |
| EBT Per EBIT | -118.10% | 356.47% | 173.46% | 292.15% | 279.69% |
| Return on Assets (ROA) | -3.72% | -16.76% | -30.47% | -29.91% | -40.27% |
| Return on Equity (ROE) | 21.44% | 113.35% | -4780.17% | -147.98% | -92.32% |
| Return on Capital Employed (ROCE) | -32.41% | -5.20% | -25.03% | -12.42% | -16.79% |
| Return on Invested Capital (ROIC) | 3.77% | -4.90% | -22.05% | -10.97% | -15.25% |
| Return on Tangible Assets | -20.15% | -92.89% | -123.61% | -88.06% | -122.76% |
| Earnings Yield | -21.65% | -177.83% | -89.53% | -65.37% | -58.24% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 62.86 | 324.96 | 38.69 |
| Payables Turnover | 2.97 | 2.87 | 7.40 | 7.73 | 7.14 |
| Inventory Turnover | 21.70 | 13.60 | 13.43 | 4.15 | 3.95 |
| Fixed Asset Turnover | 5.31 | 5.37 | 5.39 | 2.32 | 1.59 |
| Asset Turnover | 0.52 | 0.66 | 0.78 | 0.42 | 0.27 |
| Working Capital Turnover Ratio | -0.80 | -2.45 | -5.85 | -15.02 | -10.03 |
| Cash Conversion Cycle | -106.22 | -100.37 | -16.33 | 41.88 | 50.66 |
| Days of Sales Outstanding | 0.00 | 0.00 | 5.81 | 1.12 | 9.43 |
| Days of Inventory Outstanding | 16.82 | 26.84 | 27.17 | 87.94 | 92.34 |
| Days of Payables Outstanding | 123.04 | 127.21 | 49.31 | 47.19 | 51.11 |
| Operating Cycle | 16.82 | 26.84 | 32.98 | 89.07 | 101.77 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.01 | -0.01 | -0.01 | -0.02 | -0.04 |
| Free Cash Flow Per Share | -0.01 | -0.01 | -0.01 | -0.02 | -0.04 |
| Dividend Paid and CapEx Coverage Ratio | -482.57 | -12.93 | -3.70 | -13.66 | -7.99 |
| Capital Expenditure Coverage Ratio | -482.57 | -12.93 | -3.70 | -33.27 | -7.99 |
| Operating Cash Flow Coverage Ratio | -0.06 | -0.04 | -0.06 | -0.09 | -0.26 |
| Operating Cash Flow to Sales Ratio | -0.12 | -0.05 | -0.06 | -0.15 | -0.45 |
| Free Cash Flow Yield | -36.00% | -36.00% | -18.08% | -14.56% | -19.59% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -4.50 | -0.56 | -1.12 | -1.53 | -1.72 |
| Price-to-Sales (P/S) Ratio | 0.33 | 0.14 | 0.44 | 1.08 | 2.57 |
| Price-to-Book (P/B) Ratio | -0.99 | -0.64 | 53.39 | 2.26 | 1.59 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -2.78 | -2.78 | -5.53 | -6.87 | -5.10 |
| Price-to-Operating Cash Flow Ratio | -2.78 | -2.99 | -7.03 | -7.07 | -5.74 |
| Price-to-Earnings Growth (PEG) Ratio | 0.06 | 0.01 | 0.03 | 0.06 | 0.07 |
| Enterprise Value Multiple | 22.17 | 21.15 | -15.15 | -12.12 | -3.81 |
| Enterprise Value | 25.21M | 19.05M | 24.82M | 34.46M | 23.33M |
| EV to EBITDA | 22.17 | 21.15 | -15.15 | -12.12 | -3.81 |
| EV to Sales | 2.16 | 1.39 | 1.37 | 2.56 | 3.94 |
| EV to Free Cash Flow | -17.98 | -27.03 | -17.36 | -16.32 | -7.82 |
| EV to Operating Cash Flow | -18.02 | -29.12 | -22.05 | -16.81 | -8.80 |
| Tangible Book Value Per Share | -0.20 | -0.18 | -0.15 | -0.15 | -0.07 |
| Shareholders’ Equity Per Share | -0.04 | -0.03 | 0.00 | 0.07 | 0.14 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.00 | -0.40 | -0.03 | -0.02 | 0.00 |
| Revenue Per Share | 0.11 | 0.13 | 0.15 | 0.14 | 0.09 |
| Net Income Per Share | -0.01 | -0.03 | -0.06 | -0.10 | -0.13 |
| Tax Burden | 1.00 | 1.40 | 1.03 | 1.02 | 1.05 |
| Interest Burden | -1.18 | 124.88 | 1.60 | 2.92 | 1.18 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.40 | 0.45 | 0.08 | 0.57 | 0.67 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.01 | 0.05 |
| Income Quality | 1.66 | 0.19 | 0.16 | 0.22 | 0.30 |
Currency in USD
